Click on the links below to view abstracts and posters presented at this congress. All copyright remains that of the copyright holder. This page will be available for a limited period after the congress.
Oral presentation 185 Sesti
DUAL VIII: more patients met treatment targets with IDegLira (insulin degludec/liraglutide) vs. IGlar U100 by Week 26 in a 104-week randomised trial mirroring clinical practice
Oral presentation 186 Aroda
DUAL VIII: longer time to intensification with insulin degludec/liraglutide (IDegLira) vs. insulin glargine in a 104-week randomised trial mirroring clinical practice